Uniphar plc (LON:UPR - Get Free Report) reached a new 52-week high during mid-day trading on Thursday . The company traded as high as GBX 269 ($3.49) and last traded at GBX 269 ($3.49), with a volume of 12207 shares changing hands. The stock had previously closed at GBX 226 ($2.93).
Analyst Upgrades and Downgrades
Separately, Shore Capital restated a "buy" rating on shares of Uniphar in a research report on Tuesday, February 25th.
Get Our Latest Report on Uniphar
Uniphar Stock Up 19.0 %
The company has a market capitalization of £837.35 million, a price-to-earnings ratio of 18.70 and a beta of 0.75. The business's 50-day moving average is GBX 195.44 and its 200-day moving average is GBX 197. The company has a quick ratio of 0.60, a current ratio of 0.90 and a debt-to-equity ratio of 119.48.
About Uniphar
(
Get Free Report)
Headquartered in Dublin, Ireland Uniphar plc is a diversified healthcare services business servicing the requirements of more than 200 multinational pharmaceutical and medical technology
manufacturers across three divisions – Commercial & Clinical, Product Access and Supply Chain & Retail. With a workforce of more than 2,000, the Group is active in Ireland, the UK and the Benelux.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Uniphar, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Uniphar wasn't on the list.
While Uniphar currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
